acrolein has been researched along with Insulin Sensitivity in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Le, TT; Urasaki, Y | 1 |
| Boechat, SK; Neto, JGO; Oliveira, KJ; Pazos-Moura, CC; Romão, JS | 1 |
| Chan, DC; Chen, HJ; Chiu, CY; Lan, KC; Liu, SH; Wang, CC | 1 |
| Agarwal, A; Bhatnagar, A; Conklin, DJ; Das, TP; Haberzettl, P; Krivokhizhina, TV; Lorkiewicz, P; Lynch, BH; Malovichko, MV; O'Toole, TE; Rai, SN; Shah, J; Sithu, SD; Srivastava, S; Wickramasinghe, N; Zeller, I | 1 |
| Chen, B; Fu, M; Gao, S; Li, L; Liu, C; Liu, H; Ma, R; Niu, J; Wang, L; Zhang, D; Zhu, R | 1 |
| Fang, X; Gao, S; Liu, H; Ma, R; Ma, Y; Mo, F; Mu, Q; Wang, L; Wu, R; Yu, N; Zhang, D; Zhao, D; Zhu, R; Zuo, J | 1 |
| Bergheim, I; Drescher, A; Häring, HU; Hennige, AM; Machann, J; Peter, A; Sartorius, T; Schick, F; Schulz, N; Schürmann, A; Siegel-Axel, D; Weigert, C | 1 |
| Abplanalp, W; Bhatnagar, A; Conklin, DJ; Cooper, N; Haberzettl, P; Li, X; O'Toole, TE | 1 |
| Gavin, T; LoPachin, RM | 1 |
| Futawaka, K; Kasahara, M; Li, JE; Liu, TH; Moriyama, K; Tagami, T; Yamamoto, H | 1 |
| Attanasio, R; Feroe, AG; Scinicariello, F | 1 |
| Guo, FJ; Li, ML; Meng, Y; Xu, YC; Zhang, W | 1 |
| Badawy, D; El-Bassossy, HM; Fahmy, A | 1 |
1 review(s) available for acrolein and Insulin Sensitivity
| Article | Year |
|---|---|
Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety.
Topics: Acrolein; Animals; Cinnamomum zeylanicum; Diabetes Mellitus; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Signal Transduction | 2017 |
12 other study(ies) available for acrolein and Insulin Sensitivity
| Article | Year |
|---|---|
A Composition of Phytonutrients for Glycemic and Weight Management.
Topics: Acrolein; Animals; Berberine; Blood Glucose; Curcumin; Diabetes Mellitus; Disease Models, Animal; Fatty Acids; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Lipids; Mice; Obesity; Phytochemicals; Weight Gain | 2022 |
Treatment with cinnamaldehyde reduces the visceral adiposity and regulates lipid metabolism, autophagy and endoplasmic reticulum stress in the liver of a rat model of early obesity.
Topics: Acrolein; Adiposity; Animals; Autophagy; Body Weight; Disease Models, Animal; Endoplasmic Reticulum Stress; Hyperphagia; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Liver; Male; Obesity; Rats; Rats, Wistar; Triglycerides | 2020 |
Low-Dose Acrolein, an Endogenous and Exogenous Toxic Molecule, Inhibits Glucose Transport via an Inhibition of Akt-Regulated GLUT4 Signaling in Skeletal Muscle Cells.
Topics: Acrolein; Animals; Biological Transport, Active; Blood Glucose; Cell Line; Glucose; Glucose Intolerance; Glucose Transporter Type 4; Humans; Insulin Resistance; Male; Mice; Mice, Inbred ICR; Muscle Fibers, Skeletal; Muscle, Skeletal; Proto-Oncogene Proteins c-akt; Signal Transduction | 2021 |
Biomarkers of Chronic Acrolein Inhalation Exposure in Mice: Implications for Tobacco Product-Induced Toxicity.
Topics: Acrolein; Animals; Biomarkers; Endoplasmic Reticulum Stress; Endothelial Cells; Inhalation Exposure; Insulin Resistance; Leukocytes; Male; Mice; Mice, Inbred C57BL; Nicotiana; Oxidative Stress; Smoke | 2017 |
Cinnamaldehyde Ameliorates Diet-Induced Obesity in Mice by Inducing Browning of White Adipose Tissue.
Topics: Acrolein; Adipose Tissue, Brown; Adipose Tissue, White; Administration, Oral; Animals; Anti-Obesity Agents; Body Weight; Diet, High-Fat; DNA-Binding Proteins; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Gene Expression Regulation; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Transcription Factors; Uncoupling Protein 1 | 2017 |
Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity.
Topics: Acrolein; Adiposity; Animals; Astrocytes; Brain; Cell Line; Cinnamomum zeylanicum; Energy Intake; Eugenol; Glycogen; Humans; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Motor Activity; Obesity; Plant Extracts | 2014 |
Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a.
Topics: Acrolein; Cell Movement; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Insulin Resistance; MicroRNAs | 2014 |
Protein adduct formation initiates acrolein-induced endothelial cell toxicity.
Topics: Acrolein; Cell Movement; Endothelium, Vascular; Humans; Insulin Resistance; MicroRNAs | 2015 |
Cinnamaldehyde Contributes to Insulin Sensitivity by Activating PPARδ, PPARγ, and RXR.
Topics: Acrolein; Adipocytes; Cinnamomum zeylanicum; Drug Synergism; Energy Metabolism; Fatty Acids; Gene Expression; HEK293 Cells; Humans; Insulin Resistance; Muscle, Skeletal; Oxidation-Reduction; Phenoxyacetates; Pioglitazone; PPAR delta; PPAR gamma; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical; Thiazolidinediones; Transcription, Genetic; Up-Regulation | 2015 |
Acrolein metabolites, diabetes and insulin resistance.
Topics: Acetylcysteine; Acrolein; Adult; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Insulin Resistance; Male; Nutrition Surveys | 2016 |
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.
Topics: Acrolein; Animals; Berberine; Blotting, Western; Body Weight; Diabetes Mellitus, Type 2; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Rats; Rats, Wistar; Retinol-Binding Proteins, Plasma | 2008 |
Cinnamaldehyde protects from the hypertension associated with diabetes.
Topics: Acetylcholinesterase; Acrolein; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium; Diabetes Mellitus, Experimental; Hypertension; Hypoglycemic Agents; Insulin Resistance; Male; Nitric Oxide; Pioglitazone; Potassium Chloride; Rats; Rats, Wistar; Thiazolidinediones; Vasoconstriction | 2011 |